Dementia currently affects nearly one million people in the UK, a number that is expected to rise in coming decades. Alzheimer’s disease is the most commonly diagnosed type of dementia, accounting for almost 70% of cases. As understanding of the condition deepens, so too does our ability to treat, manage, and one day, prevent it. In this article, we explore the latest research on dementia, how these advances may affect you, and what families should know right now.
New Dementia Treatments Showing Promise
Recent years have seen significant advancements in disease-modifying therapies for Alzheimer’s disease. Two notable drugs—Lecanemab (marketed as Leqembi) and Donanemab (marketed as Kisunla)—have demonstrated potential in slowing the progression of early-stage Alzheimer’s by targeting and reducing amyloid plaques in the brain.
In 2024, both Lecanemab and Donanemab received approval from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for use in adults with early-stage Alzheimer’s disease.
However, the National Institute for Health and Care Excellence (NICE) has not recommended these treatments for use within the NHS, citing concerns over cost-effectiveness. As a result, access to these medications is currently limited to private healthcare settings.
These developments mark a significant step forward in advances in dementia research, offering hope that future treatments may not only manage symptoms but also alter the course of the disease when administered early.
Easier and Earlier Dementia Diagnosis
Obtaining a timely and accurate diagnosis of dementia has traditionally involved memory assessments, MRI scans, and sometimes invasive procedures like lumbar punctures. However, there have been recent advancements in blood tests for dementia diagnosis.
Blood-Based Biomarker Tests
These blood tests are bringing us closer to easier and earlier dementia diagnoses. These blood tests aim to detect levels of amyloid and tau proteins, which are key indicators of Alzheimer’s disease, long before symptoms appear.
A study published in Nature Medicine demonstrated that blood tests measuring minute levels of amyloid-β and tau proteins circulating in the bloodstream can identify Alzheimer’s-related pathology with over 90% accuracy.
In the UK, the Blood Biomarker Challenge (an initiative led by Alzheimer’s Society, Alzheimer’s Research UK, and the National Institute for Health and Care Research) is underway to pilot the use of these blood tests in NHS settings. The goal is to make such diagnostics widely available within the next five years.
These developments could revolutionise dementia diagnosis, offering a cost-effective, non-invasive alternative to current methods and enabling earlier intervention for those affected.
Artificial Intelligence (AI) for Dementia Diagnosis
Artificial Intelligence (AI) is opening new doors in early dementia detection and diagnosis. AI-powered tools can now analyse brain scans and even language patterns to spot early warning signs of cognitive decline.
A study by the University of Cambridge has shown that machine learning models can identify early-stage Alzheimer’s symptoms up to a year before current diagnostic methods. This technology has the potential to personalise treatment, speed up diagnosis, and ultimately improve care outcomes.
Dementia Prevention Strategies
Although there is no cure yet, many studies confirm that certain lifestyle changes can reduce the risk of developing dementia by contributing to better brain health These include:
- Regular physical activity
- Healthy eating (such as the Mediterranean diet)
- Social engagement
- Cognitive stimulation
The Lancet Commission on Dementia Prevention found that up to 40% of dementia cases could be delayed or even prevented through addressing modifiable risk factors like hypertension, obesity, hearing loss, and isolation.
Encouraging your loved ones to stay mentally and physically active can have long-lasting protective effects.
Genetic Discoveries and Rare Dementias
Beyond Alzheimer’s, researchers are making progress in understanding rarer forms of dementia, such as frontotemporal dementia and dementia with Lewy bodies. Studies led by Dementias Platform UK are helping to map the genetic causes and unique biological signatures of these conditions.
This research is paving the way for tailored treatments and earlier diagnoses, offering reassurance to families who may have felt left behind by more general Alzheimer’s-focused studies.
How Dementia Research Affects You
The latest updates on dementia offer something valuable for everyone—whether you’re living with dementia, supporting someone who is, or working in a care setting. New treatments bring hope of slowing decline. Earlier diagnoses allow for better care planning, while lifestyle advice gives people the chance to take action, even before symptoms appear.
For those working in residential dementia care, this research shapes how care is delivered, ensuring that it is more personalised, more proactive, and more informed by evidence.
Looking Ahead
The future of dementia care is brighter than it has ever been. Advances in dementia research are beginning to change lives, not just in laboratories, but in homes, communities, and care settings across the UK.
Understanding these developments allows families to act with greater confidence and clarity. Whether it’s through access to emerging treatments, earlier diagnoses, or healthier living, progress is being made and its progress that matters.
Dementia Care Advancements at B&M Care
At B&M Care, we are committed to staying at the forefront of dementia care. We regularly review the latest research and innovations to ensure our homes reflect best practices and emerging technologies. This includes the recent introduction of PainChek: a clinically validated pain assessment tool that uses facial recognition and AI to help staff identify and manage pain in residents who may struggle to communicate discomfort.
By embracing advancements like this, we continue to provide thoughtful, personalised care that evolves alongside the science.
Staying Informed and Getting Support
To stay up to date on advances in dementia research, consider following organisations like: